OSTEOPOROSIS IS the most common human metabolic
|
|
- Shanon Malone
- 5 years ago
- Views:
Transcription
1 JOURNAL OF BONE AND MINERAL RESEARCH Volume 16, Number 8, American Society for Bone and Mineral Research Relation Between Vitamin D Insufficiency, Bone Density, and Bone Metabolism in Healthy Postmenopausal Women PEDRO MEZQUITA-RAYA, 1 MANUEL MUÑOZ-TORRES, 1 JUAN DE DIOS LUNA, 2 VICTORIA LUNA, 1 FRANCISCA LOPEZ-RODRIGUEZ, 1 ELENA TORRES-VELA, 1 and FERNANDO ESCOBAR-JIMÉNEZ 1 ABSTRACT Although only few postmenopausal women exhibit biochemical signs of hypovitaminosis D, vitamin D insufficiency has been shown to have adverse effects on bone metabolism and could be an important risk factor for osteoporosis and fracture. We determined serum levels of 25-hydroxyvitamin D [25(OH)D], intact parathyroid hormone (ipth), bone turnover markers, dietary calcium intake, and bone mineral density (BMD; measured by dual X-ray absorptiometry) in 161 consecutive ambulatory women, healthy except for osteoporosis, referred to a bone metabolic unit. The prevalence of vitamin D insufficiency [25(OH)D < 15 ng/ml] was 39.1%. 25(OH)D was lower in the osteoporotic subjects ( ng/ml vs ng/ml; p < 0.001). After controlling for all other variables, lumbar spine (LS) BMD was found to be significantly associated with 25(OH)D, body mass index (BMI), and years after menopause (YSM) (R ; p < 0.001). For femoral neck (FN), significant independent predictors of BMD were YSM, BMI, ipth, and 25(OH)D (R ; p < 0.001). The probability of meeting osteoporosis densitometric criteria was higher in the vitamin D insufficiency group (odds ratio [OR], 4.17, ) after adjusting by YSM, BMI, ipth, and dietary calcium intake. Our study shows that vitamin D insufficiency in an otherwise healthy postmenopausal population is a common risk factor for osteoporosis associated with increased bone remodeling and low bone mass. (J Bone Miner Res 2001;16: ) Key words: vitamin D insufficiency, osteoporosis, bone mineral density, bone turnover, postmenopausal women INTRODUCTION OSTEOPOROSIS IS the most common human metabolic bone disorder. It has been defined as a disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk. (1,2) It is an important public health issue in postmenopausal women and if untreated, more than half of white women will experience fractures during their lifetime. Normal bone metabolism depends on the presence of appropriate repletion of vitamin D. The importance of vitamin D insufficiency is related primarily to bone integrity. Although only few patients with osteoporosis exhibit obvious biochemical signs of hypovitaminosis D, vitamin D insufficiency has been shown to have adverse effects on calcium metabolism, osteoblastic activity, matrix ossification, bone mineral density (BMD), and bone remodeling. (3 6) Determination of serum 25-hydroxyvitamin D [25(OH)D] is the most clinically reliable indicator of vitamin D status. Thus, low serum 25(OH)D concentration is associated with secondary hyperparathyroidism, increased bone turnover, reduced BMD, and increased risk of osteoporotic fractures. (4 6) In addition, administration of vitamin D to the elderly slows bone turnover, increases 1 Bone Metabolic Unit, Endocrinology Division, University Hospital San Cecilio, Granada, Spain. 2 Biostatistics Department, School of Medicine, Granada, Spain. 1408
2 VITAMIN D INSUFFICIENCY IN POSTMENOPAUSAL WOMEN 1409 BMD, and can reduce the rates of fragility fractures. (7) However, although previous studies have established the importance of vitamin D insufficiency in selected groups at risk (8 10) such as elderly patients who are housebound, living in a nursing home, or general medical inpatients, the role of this disorder on bone metabolism and postmenopausal bone loss is still controversial. (11 14) Therefore, we assessed the relationships between vitamin D insufficiency, parathyroid hormone (PTH) concentrations, BMD, and biochemical markers of bone turnover in a healthy (except for osteoporosis), communitydwelling, ambulatory postmenopausal women. MATERIALS AND METHODS Study subjects From November 1998 to April 1999, 363 Spanish women were referred by general practitioners to our unit for osteoporosis screening in Granada, Spain (latitude N and longitude 3 35 W). The study was approved by the Investigation Committee of the University Hospital San Cecilio. At the clinic, detailed medical histories and biochemical studies were performed to identify any causes for low BMD. After giving informed consent, 161 postmenopausal women were recruited. All were white; ambulatory; in good health except for osteoporosis; had normal values for serum calcium and phosphorus; and did not present renal, hepatic, gastrointestinal, or thyroid diseases or any other secondary causes for low BMD or serum vitamin D levels. None of them had been treated with calcium supplements, vitamin D preparations, hormone therapy, antiresorptive therapy, thiazides, steroids, or other medications that might affect BMD or vitamin D metabolism. Assessment of dietary calcium intake Dietary calcium intake was assessed by a detailed weekly food-frequency interview performed by a single expert dietitian. Each subject was asked to indicate the type and quantity of all food and drink consumed over a 1-week period and the dietary calcium content was calculated using a local food composition table. (15) They were entered in a database and analyzed by a single trained operator using a computer program to obtain the average daily intake of calcium. Bone density measurements and radiography BMD was measured by dual-energy X-ray absorptiometry (Hologic QDR 1000 ; Hologic, Inc., Waltham, MA, USA) at lumbar spine (LS) and femoral neck (FN). The in vivo precision (CV) was better than 2% at both sites of measurement. A total of 2552 healthy normal subjects (1331 females and 1221 males) served to establish the mean BMD in the healthy Spanish population and to calculate the T score (number of SDs of the patient s value from the mean of young control population) and Z score for each BMD measurement (number of SDs of the patient s value from the mean control population in a 5-year-age band). The characteristics of this reference population have been described previously. (16) According to the World Health Organization (WHO) criteria, (17) we considered osteoporosis when the LS and/or FN T score was equal or below 2.5 SD. Vertebral fractures, calcifications, or other significant degenerative changes were assessed by X-ray study and corrected according to the method of Orwoll. (18) Anteroposterior and lateral X-rays of the thoracic and lumbar spine were taken for all women to assess the presence of fractures. The anterior, central, and posterior height of each of the 13 vertebral bodies from Th4 to L4 were measured. Vertebral fracture was defined as a reduction of as least 20% in the anterior, central, or posterior vertebral height according to the following criteria: (a) anterior wedge deformity ratio of anterior to posterior height 80%; (b)concavity deformity ratio of central to posterior height 80%; (c) crush deformity ratio of posterior height to posterior height of the adjacent vertebra 80%. Biochemical measurements Morning fasting samples of venous blood were taken. Serum 25(OH)D 3 (25-hydroxyvitamin D 125 I radioimmunoassay [RIA]; reference value (RV), ng/ml; Incstar Corp., Stillwater, MN, USA) and intact PTH (ipth; Immulite Intact PTH; RV, pg/ml; Diagnostic Products Corp., Los Angeles, CA, USA) were assayed. Serum total alkaline phosphatase (talp; Hitachi 704 autoanalyzer; RV, IU/liter;Boehringer Mannheim, Mannheim, Germany), bone ALP (balp; Tandem-T, Ostase Immuno- RadioMetric Assay; RV, g/ml; Hybritech Europe, Liege, Belgium), osteocalcin (OC; Osteocalcin 125 I RIA; RV, ng/ml; Incstar Corp.), tartrate-resistant acid phosphatase (TRAP; Hitachi 704 autoanalyzer; RV: 7 IU/liter; Boehringer Mannheim), fasting urine crosslinked carboxy-terminal telopeptide of type I collagen corrected by urinary creatinine (CTX; -CrossLaps RIA; RV postmenopausal women, g/mmol; Osteometer Biotech, Herlev, Denmark), and fasting urine calcium/ creatinine ratio were determined as bone turnover markers. The samples were analyzed in multiple analysis; the interassay CVs were % for 25(OH)D, 7% for ipth, % for balp, 2.2% for talp, 3.5% for OC, 13.7% for CTX, and 2.2% for TRAP. Definition of vitamin D insufficiency We selected 15 ng/ml (37 nm) as the lower 25(OH)D cut-off in our analysis, based on published data showing that serum ipth is increased in patients who have 25(OH)D concentrations equal to or below 15 ng/ml. (8,19,20) Moreover, a specific cut point was calculated as the 25(OH)D concentration at which maximum signification is reached comparing bone turnover markers and ipth (28 ng/ml). Statistical analysis Group means were compared using the two-tailed nonpaired Student s t-test. Simple linear regression analysis was used to study the relationship among 25(OH)D, ipth, and BMD measurements. Multiple linear regression was
3 1410 MEZQUITA-RAYA ET AL. TABLE 1. CLINICAL CHARACTERISTICS OF 161 POSTMENOPAUSAL WOMEN Total (n 161) 25(OH)D 15 (ng/ml; n 98) 25(OH)D 15 (ng/ml; n 63) notp (n 83) OTP (n 78) Age (years) * YSM * BMI (kg/m 2 ) * LS BMD (g/cm 2 ) * LS T score FN BMD (g/cm 2 ) * FN T score * 25(OH)D (ng/ml) * ipth (pg/ml) * Ca intake (mg/day) Data are mean SD. For ipth, RV pg/ml. OTP, osteoporotic patients; notp: nonosteoporotic patients. * p 0.05 versus nonosteoporotic patients; p 0.05 versus noninsufficiency 25(OH)D patients. used to estimate adjusted -coefficients for changes in BMD; also, partial correlations were completed to measure percentage variance explained by each covariate. Logistic regression was used to estimate crude and adjusted odds ratio (OR) for the dichotomous outcomes of osteoporosis. The Hosmer and Lemeshow goodness-of-fit test used in the models resulted in nonsignificant (p 0.3). The years since menopause (YSM) variable was entered in the model in the following categories: 0 10 YSM, YSM, YSM, and 30 YSM, the first being used as the reference category. The ipth levels variable was entered in the model in two categories using a cut-off at 72 pg/ml, the upper limit of the normal range measured in our laboratory. The reference category was the ipth 72 pg/ml group. The body mass index (BMI; kg/m 2 ) variable was entered in the model in two categories, with (BMI 30 kg/m 2 ) or without (BMI 30 kg/m 2 ) obesity, (21,22) with the obese group as the reference category. The dietary calcium intake variable was entered in the model in three categories: below to 500 mg/day, between 500 and 1000 mg/day, and greater than 1000 mg/day, with the upper category as the reference. We tested for differences in the relationship of vitamin D levels to change in these measurements by including interaction terms for vitamin D status in the models. None of these interaction terms were significant. Analyses were performed with adjustment for YSM, BMI, ipth, and dietary calcium intake. Statistical significance was defined as a value of p All analyses were performed in SPSS, version (SPSS Ltd., Chicago, IL, USA) using the multiple regression program and logistic regression program when calculating 95% CIs and p values. RESULTS Clinical characteristics The characteristics of the patients are shown in Table 1. The mean ( SD) serum 25(OH)D concentration for all 161 patients was ng/ml. The prevalence of vitamin D insufficiency [circulating 25(OH)D equal or less than 15 ng/ml] was 39.1%. According to the WHO criteria, (18) 83 patients (51.6%) were considered nonosteoporotic (normal bone mass or osteopenic; T score 2.5) and 78 patients (48.4%) were osteoporotic (T score 2.5). Forty-five women were diagnosed as having vertebral fracture, 19 (30.2%) in the vitamin D insufficiency group and 26 (26.6%) in the normal vitamin D group. Thirty-four subjects (43.6%) of the osteoporotic group had prevalent vertebral fractures. The dietary calcium intake was below the recommended dietary allowance (1500 mg/day for postmenopausal women) (23) in the entire sample. There were significant linear correlations between 25(OH)D, age, and YSM (age vs. 25(OH)D: r 0.247, p 0.002; YSM vs. 25(OH)D: r 0.317, p 0.001) and between ipth, age, and YSM (age vs. ipth: r 0.213, p 0.007; YSM vs. ipth: r 0.256, p 0.001). 25(OH)D, ipth, and BMD The average serum 25(OH)D was lower in the osteoporotic group (Table 1). Serum ipth levels were higher both in the osteoporotic and in the vitamin D insufficiency groups (Table 1) and even higher in subjects with vitamin D insufficiency independently of bone status (Fig. 1). More interestingly, the subjects with vitamin D insufficiency had a significantly lower BMD, with an average that fell 0.81 SD below the expected for their age at LS. A strong negative linear correlation was found between ipth and 25(OH)D (Fig. 2). There was a significant linear correlation between 25(OH)D and BMD at LS and FN (Fig. 3). Also, there was a significant linear correlation between ipth and BMD at LS (ipth vs. BMD [g/cm 2 ]: r 0.305, p 0.001) and FN (ipth vs. BMD [g/cm 2 ]: r 0.351, p 0.001). Bone turnover markers The mean values of all biochemical markers of bone turnover exhibited no differences between 25(OH)D 15 ng/ml and 25(OH)D 15 ng/ml groups or osteoporotic and
4 VITAMIN D INSUFFICIENCY IN POSTMENOPAUSAL WOMEN 1411 FIG. 1. ipth levels according to 25(OH)D and BMD groups. OTP, T score at LS or FN 2.5; notp, T score at LS or FN 2.5. levels, BMI, and YSM (Table 3). This final model explained 25.3% of the observed variance in lumbar spine BMD. For FN BMD, significant independent predictors of BMD were YSM, BMI, ipth, and serum 25(OH)D levels. The final model explained 36.8% of the observed variance in FN BMD (Table 3). Overall, the serum 25(OH)D accounted for a 10.04% of the variance in BMD at LS after adjusting for BMI and YSM and a 2.52% at FN after adjusting for YSM, ipth, and BMI. Taking into account the total effect of YSM, BMI, dietary calcium intake, ipth levels, and 25(OH)D levels, the YSM variable was associated the most strongly with OP followed by 25(OH)D levels and BMI (Table 4). The effects of ipth and dietary calcium intake were not statistically significant, but they should not be ignored because they increase the global significance of the model. DISCUSSION FIG. 2. Correlation between 25(OD)D and ipth. nonosteoporotic groups except CTX, which was higher in the vitamin D insufficiency group (CTX: g/ mmol vs g/mmol; p 0.012) and correlated with 25(OH)D (r 0.240; p 0.002). Also, there were internal significant correlations among bone turnover markers and between ipth and bone turnover markers (Table 2). However, CTX, talp, balp, and ipth were higher in patients with 25(OH)D 28 ng/ml (CTX: g/mmol vs g/mmol, p 0.012; talp: IU/liter vs IU/liter, p 0.045; balp: g/ml vs g/ml, p 0.006; ipth: pg/ml vs pg/ml, p 0.001). Bivariate and multivariate analysis After controlling for all other variables, LS BMD was found to be significantly associated with serum 25(OH)D Our study shows that vitamin D insufficiency is a common risk factor for osteoporosis, associated with increased bone remodeling and postmenopausal osteoporosis, in healthy (except for osteoporosis), community-dwelling, ambulatory postmenopausal women. In previous studies of elderly housebound people, medical inpatients, and nursing home residents, one-quarter to one-half had low vitamin D levels. (8 10,24) However, in our study, with ambulatory subjects without secondary causes or medications that might affect bone density, the prevalence of vitamin D insufficiency was 39.1%. The high frequency of vitamin D insufficiency in postmenopausal women in this sunny region should be of concern. The main factors contributing to vitamin D insufficiency are poor vitamin D intake, low sunlight exposure (staying indoors), and disorders or drugs known to affect vitamin D metabolism. (25) In our population, secondary causes affecting vitamin D metabolism were excluded. Serum 25(OH)D was measured from November to April, a winter period where there is normally no cyclical seasonal variation. In other countries in which dairy products are fortified with vitamin D, it is well known that calcium-deficient diets tend to be vitamin D-deficient too, because a single food, milk, is the principal dietary source of both of these nutrients. (26) In our country, this finding may be justified by the lack of a governmental mandate that food be supplemented with vitamin D. Hence, cutaneous synthesis would be the major source of the vitamin in ambulatory women of this age group. This could be an explanation for the low serum levels of 25(OH)D found in our sample. In our study, the pathogenic role of vitamin D insufficiency in the decreased bone mass is suggested by the significant correlation between 25(OH)D and BMD in LS and FN. Moreover, the average serum 25(OH)D was lower in the osteoporotic group and women with vitamin D insufficiency had a significantly lower BMD. Secondary hyperparathyroidism is a well-known consequence of vitamin D insufficiency. (3,24,27 29) Our data show a strong negative correlation between ipth and 25(OH)D and a significant correlation among ipth and bone turnover markers. This
5 1412 MEZQUITA-RAYA ET AL. FIG. 3. Correlation between 25(OD)D and BMD. (A) LS; (B) FN. biochemical picture suggests that increased concentrations of PTH might play an important role in the development of increased bone remodeling and bone loss in postmenopausal women with vitamin D insufficiency. Villarreal et al. (5) could not find in their population a correlation between 25(OH)D and ipth at physiological concentrations. In contrast, in our study and others reported previously (8,30) 25(OH)D is involved directly in the feedback control of PTH, even at physiological concentrations. We found that aging may lead to an increase in PTH levels and a decrease in vitamin D concentrations in postmenopausal women, as previous reports show. (31) Despite this fact, these findings are not likely to account entirely for the low bone mass found in the majority of our vitamin D insufficiency subjects. We observed that 25(OH)D and ipth still predict independently BMD at LS and FN, respectively, after adjusting for YSM, dietary calcium intake, and BMI. Vitamin D status appeared to be less related to proximal femur than to LS BMD. This may be caused by the fact that other mechanical factors (i.e., physical activity and weight) could influence proximal femur BMD to a higher extent. Moreover, the sex hormone deficiency makes LS bone more susceptible for vitamin D insufficiency. As it has been suggested previously, estrogens deficiency potentiates the effect of PTH excess because of vitamin D insufficiency. (32) Furthermore, hyperparathyroidism predisposes to cortical rather than cancellous bone loss, which would be more obvious at FN compared with LS and also may explain that ipth was a significant independent predictor of BMD at FN, influencing to a lower extent the vertebral bone mass. This dual effect of PTH on bone has been described classically in patients with primary hyperparathyroidism. (33,34) There were no differences in biochemical markers of bone turnover between 25(OH)D 15 ng/ml and 25(OH)D 15 ng/ml groups or osteoporotic and nonosteoporotic groups, except CTX. However, CTX, talp, balp, and ipth levels were higher in patients with 25(OH)D 28 ng/ml and there was a significant positive correlation between ipth and bone turnover markers. This result supports previous data suggesting that the 25(OH)D threshold level needed to prevent secondary hyperparathyroidism and bone loss should be higher. (26,27,35 38) Serum 25(OH)D is the most clinically available measurement of vitamin D status reflecting lifestyle and dietary habits. (25) Assuming a cut-off level of 15 ng/ml in our sample, the probability of meeting osteoporosis densitometric criteria was higher in the vitamin D insufficiency group, after adjusting for YSM, BMI, serum ipth levels and dietary calcium intake. These results could suggest another effect of vitamin D on bone metabolism independently of PTH excess as described in animal models and in vitro studies. (39,40) Limitations of our study include those associated with cross-sectional studies. All the subjects studied attended our unit for screening of osteoporosis; so, our sample is not representative of the general population. Otherwise, we probably have underestimated the prevalence of hypovitaminosis D by not identifying subjects with low serum 1,25(OH)D concentrations despite adequate serum 25(OH)D concentrations. Our most interesting finding shows that vitamin D contributes for 10% of the BMD variance at LS and 2.5% of BMD at FN and that the probability of meeting osteoporosis criteria is significantly higher in the vitamin D insufficiency group. Vitamin D contribution to the BMD is not negligible and represents an attractive candidate agent for its use in preventive interventions like systematic supplementation of dairy products. In conclusion, we found that vitamin D insufficiency in an otherwise healthy postmenopausal population is a common risk factor for osteoporosis associated
6 VITAMIN D INSUFFICIENCY IN POSTMENOPAUSAL WOMEN 1413 TABLE 2. CORRELATIONS AMONG ipth AND BIOCHEMICAL MARKERS OF BONE TURNOVER Variable ipth (pg/ml) balp ( g/ml) talp (IU/liter) OC (ng/ml) uca/cr ratio CTX ( g/mmol) balp talp * OC uca/cr ratio CTX 0.319* 0.366* TRAP (IU/liter) * 0.390* uca/cr ratio, fasting urine calcium/creatinine ratio. * p 0.001; p 0.005; p TABLE 3. MULTIPLE LINEAR REGRESSION ANALYSIS OF BMD Variable LS Partial correlation p FN Partial correlation p Constant (OH)D (ng/ml) YSM BMI (kg/m 2 ) BMI YSM ipth (pg/ml) (OH)D Model R ; p R ; p TABLE 4. BIVARIATE AND MULTIVARIATE ANALYSIS Variable Bivariate Multivariate OR CI 95% OR CI 95% YSM 1.09 a a 1.08 a a 10 years years years years Serum 25(OH)D levels (ng/ml) 0.9 a a 0.89 a a 15 ng/ml ng/ml BMI (kg/m 2 ) 0.92 a a 0.87 a a 30 kg/m kg/m Serum ipth levels (pg/ml) 1.02 a a 0.99 a a 72 pg/ml pg/ml Dietary calcium intake 0.69 a a 0.6 a a mg/day mg/day mg/day a As continuous variable. with increased bone remodeling and low bone mass. Because replacement therapy is inexpensive, simple, and safe, a widespread screening for vitamin D insufficiency and the normalization of vitamin D status should alter our routine medical practice and have important public health implications even in southern latitude countries. ACKNOWLEDGMENT We express our gratitude to Andrew F. Stewart for his exciting critical review of this article. This work was supported by a grant from Servicio Andaluz de
7 1414 MEZQUITA-RAYA ET AL. Salud (Exp 97/44 304) and the Hospital Clínico Foundation. REFERENCES 1. Consensus Development Conference 1994 Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94: Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N 1994 The diagnosis of osteoporosis. J Bone Miner Res 9: Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD 1982 Vitamin D, and bone health in the elderly. Am J Clin Nutr 35: Lukert B, Higgins J, Stoskopf M 1992 Menopausal bone loss is partially regulated by dietary intake of vitamin D. Calcif Tissue Int 51: Villareal DT, Civitelli R, Chines A, Avioli LV 1991 Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. J Clin Endocrinol Metab 72: Khaw KT, Sneyd MJ, Compston J 1992 BMD, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ 305: Chapuy MC, Arlot ME, Duboeuf F, Crouzet B, Delmas PD, Meunier PJ 1992 Vitamin D, and calcium to prevent hip fractures in elderly women. N Engl J Med 327: Gloth FM, Gundberg CM, Hollis BW, Haddad JG, Tobin JD 1995 Vitamin D deficiency in homebound elderly persons. JAMA 274: McKenna MJ 1992 Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93: Goldray D, Mizrahi-Sasson E, Merdler C, Edelstein Singer M, Algoetti A, Eisenberg Z, Jaccard N, Weisman Y 1989 Vitamin D deficiency in elderly patients in a general hospital. J Am Geriatr Soc 37: Silverberg SJ, Shane E, De la Cruz L, Segre GV, Clemens TL, Bilezikian JP 1989 Abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D3 formation in women with osteoporosis. N Engl J Med 320: Tsai K, Ebeling PR, Riggs BL 1989 Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women. J Clin Endocrinol Metab 69: Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Riggs BL 1991 Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function, and age in women: Evidence of an age-related intestinal resistance to 1,25- dihydroxyvitamin D action. J Bone Miner Res 6: Prince RL, Dick I, Devine A, Price RI, Gutteridge DH, Kerr D, Criddle A, Garcia Webb P, St John A 1995 The effect of menopause and age on calciotropic hormones: A crosssectional study of 655 healthy women aged 35 to 90. J Bone Miner Res 10: Fernandez-Lloret S, Valenzuela-Ruiz A, Burgaleta-Mezo E, Ortiz-Vergara M 1997 Tablas de composición de alimentos. In: Fernandez-Lloret S (ed.) Tablas de Composición: Alimentos, Dietas Artificiales y Productos Infantiles, 3rd ed. Universidad de Granada, Granada, Spain, pp Diaz Curiel M, Carrasco de la Peña JL, Honorato Perez J, Perez Cano R, Rapado A, Ruiz Martinez I 1997 Study of BMD in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis. Osteoporos Int 7: Orwoll ES, Oviatt SK, Mann T 1990 The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 70: Report of a World Health Organization (WHO) Study group 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 843: Webb AR, Pilbeam C, Hanafin N, Holick MF 1990 An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr 51: Lips P, Wiersinga A, van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, Delmas PD, van der Vijgh WJ 1988 The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 67: Sociedad Española para el Estudio de la Obesidad (SEEDO) 1996 Spanish consensus for the evaluation of obesity and the performance of epidemiologic studies. Med Clin (Barc) 107: Report of a World Health Organization (WHO) Consultation on Obesity 1998 Obesity: Preventing and managing the global epidemic. In: Program of Nutrition, Family and Reproductive Health. WHO, Geneva, Switzerland, pp National Institutes of Health Consensus Conference 1994 Optimal calcium intake. JAMA 272: Thomas MK, Lloyd Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS 1998 Hypovitaminosis D in medical inpatients. N Engl J Med 338: Silverberg SJ, Fitzpatrick LA, Bilezikian JP 1996 The role of parathyroid hormone and vitamin D in the pathogenesis of osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds.) Osteoporosis. Academic Press, San Diego, CA, USA, pp Dawson-Hughes B, Harris SS, Krall EA, Dallal GE 1997 Effect of calcium and vitamin D supplementation on BMD in men and women 65 years of age older. N Engl J Med 337: Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ 1997 Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7: Frame B, Parffit AM 1978 Osteomalacia: Current concepts. Ann Intern Med 89: Stanbury SW 1981 Vitamin D and hyperparathyroidism. J R Coll Physicians Lond 15: Haden ST, Fuleihan GEH, Angell JE, Cotran NM, LeBoff MS 1999 Calcidiol and PTH levels in women attending an osteoporosis program. Calcif Tissue Int 64: Marcus R, Madvig P, Young G 1984 Age related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab 58: Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp Snijders C, Bezemer PD, Bouter LM 1995 Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and BMD in elderly women. J Bone Miner Res 10: Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV 1989 Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4: Wishart J, Horowitz M, Need A, Nordin BEC 1990 Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism. Arch Intern Med 150: Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G 1995 Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 61: Malabanan A, Veronikis IE, Holick MF 1998 Redefining vitamin D insufficiency. Lancet 351:
8 VITAMIN D INSUFFICIENCY IN POSTMENOPAUSAL WOMEN McKenna MJ, Freaney R 1998 Secondary hyperparathyroidism in the elderly: Means to defining hypovitaminosis D. Osteoporosis Int 8(Suppl 2):S3 S Thomas MK, Demay MB 2000 Vitamin D deficiency and disorders of vitamin D metabolism. Endocrinol Metab Clin North Am 29: Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW 1998 The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13: Finkelman RD, Linkhart TA, Mohan S, Lau KH, Baylink DJ, Bell NH 1991 Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor in rat bone: Possible mechanism for impaired osteoinduction. Proc Natl Acad Sci USA 88: Address reprint requests to: Manuel Muñoz-Torres, M.D, Plaza Isabel La Católica, 2, 3 Granada 18009, Spain Received in original form August 8, 2000; in revised form February 13, 2001; accepted March 1, 2001.
Vitamin D Status of an Outpatient Clinic Population
Calcif Tissue Int (2001) 69:263 267 DOI: 10.1007/s002230010054 2001 Springer-Verlag New York Inc. Vitamin D Status of an Outpatient Clinic Population L. Margiloff, 1 S. S. Harris, 2 S. Lee, 3 R. Lechan,
More informationSkeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationVITAMIN D IS REQUIRED FOR EFficient
ORIGINAL CONTRIBUTION Occult Vitamin D Deficiency in Postmenopausal US Women With Acute Hip Meryl S. LeBoff, MD Lynn Kohlmeier, MD Shelley Hurwitz, PhD Jennifer Franklin John Wright, MD Julie Glowacki,
More informationElecsys bone marker panel. Optimal patient management starts in the laboratory
bone marker panel Optimal patient management starts in the laboratory Complete solution for osteoporosis The most complete bone metabolism panel on a single platform bone marker assays are important diagnostic
More informationOsteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men
Osteoporos Int (1999) 10:265 270 ß 1999 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Bone Mineral Density and Vertebral Fractures
More informationAnnie WC Kung, Keith DK Luk, LW Chu, and Peter KY Chiu
Age-related osteoporosis in Chinese: an evaluation of the response of intestinal calcium absorption and calcitropic hormones to dietary calcium deprivation 1 3 Annie WC Kung, Keith DK Luk, LW Chu, and
More informationThe Skeletal Response to Aging: There s No Bones About It!
The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium
More informationBMD: A Continuum of Risk WHO Bone Density Criteria
Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris
More informationFragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey
Fragile Bones and how to recognise them Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Osteoporosis Osteoporosis is a skeletal disorder characterised by compromised bone
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 7, August 2014
HYPOVITAMINOSIS D IN INDIAN FEMALES WITH POSTMENOPAUSAL OSTEOPOROSIS DR. SHAH WALIULLAH 1 DR. VINEET SHARMA 2 DR. R N SRIVASTAVA 3 DR. YASHODHARA PRADEEP 4 DR. A A MAHDI 5 DR. SANTOSH KUMAR 6 1 Research
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 116 No 1179 ISSN 1175 8716 Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency Fiona Wu, Toni Staykova, Anne Horne, Judy Clearwater,
More informationNIH Public Access Author Manuscript J Am Coll Nutr. Author manuscript; available in PMC 2009 August 20.
NIH Public Access Author Manuscript Published in final edited form as: J Am Coll Nutr. 2008 April ; 27(2): 274 279. Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older
More informationRobin M Daly, Nicole Petrass, Shona Bass, and Caryl A Nowson
The skeletal benefits of calcium- and vitamin D 3 fortified milk are sustained in older men after withdrawal of supplementation: an 18-mo follow-up study 1 3 Robin M Daly, Nicole Petrass, Shona Bass, and
More informationClinician s Guide to Prevention and Treatment of Osteoporosis
Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening
More informationThe Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels
CLINICAL RESEARCH STUDY The Relationship Between Serum 25(OH)D and Parathyroid Hormone Levels Walid Saliba, MD, MPH, a Ofra Barnett, PhD, a Hedy S. Rennert, MPH, a Idit Lavi, MA, a Gad Rennert, MD, PhD
More informationThe effect of sun exposure on 25-hydroxyvitamin D concentrations in young healthy subjects living in the city of São Paulo, Brazil
Brazilian Journal of Medical and Biological Research (2007) 40: 1653-1659 25-Hydroxyvitamin D status in young healthy subjects ISSN 0100-879X 1653 The effect of sun exposure on 25-hydroxyvitamin D concentrations
More informationStudy of secondary causes of male osteoporosis
Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos
More informationBone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome
Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome Thomas et al. Nutrition Journal (2015) 14:99 DOI 10.1186/s12937-015-0092-2 RESEARCH Open Access Acute effect of a supplemented
More informationVitamin D Deficiency and Bone Health in Healthy Adults in Finland: Could This Be a Concern in Other Parts of Europe?
JOURNAL OF BONE AND MINERAL RESEARCH Volume 16, Number 11, 2001 2001 American Society for Bone and Mineral Research Vitamin D Deficiency and Bone Health in Healthy Adults in Finland: Could This Be a Concern
More informationThe Role of the Laboratory in Metabolic Bone Disease
The Role of the Laboratory in Metabolic Bone Disease Howard Morris PhD, FAACB, FFSc(RCPA) President, IFCC Professor of Medical Sciences, University of South Australia, Clinical Scientist, SA Pathology
More informationInfluence of vitamin D levels on bone mineral density and osteoporosis
Influence of vitamin D levels on bone mineral density and osteoporosis Mir Sadat-Ali, a Abdulmohsen H. Al Elq, b Haifa A. Al-Turki, c Fathma A. Al-Mulhim, d Amein K. Al-Ali e From the Departments of a
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationAdditional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015. Dr.
Additional Research is Needed to Determine the Effects of Soy Protein on Calcium Binding and Absorption NDFS 435 3/26/2015 Dr. Tessem Osteoporosis is a public health problem in all stages of life. Many
More informationForteo (teriparatide) Prior Authorization Program Summary
Forteo (teriparatide) Prior Authorization Program Summary FDA APPROVED INDICATIONS DOSAGE 1 FDA Indication 1 : Forteo (teriparatide) is indicated for: the treatment of postmenopausal women with osteoporosis
More informationComparison of Bone Density of Distal Radius With Hip and Spine Using DXA
ORIGINAL ARTICLE Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA Leila Amiri 1, Azita Kheiltash 2, Shafieh Movassaghi 1, Maryam Moghaddassi 1, and Leila Seddigh 2 1 Rheumatology
More informationAPPLIED NUTRITIONAL INVESTIGATION INTRODUCTION
APPLIED NUTRITIONAL INVESTIGATION Low Serum Concentrations of 25-Hydroxyvitamin D in Young Adult Japanese Women: A Cross Sectional Study Kazutoshi Nakamura, MD, MPH, Mitsue Nashimoto, BA, Shigeki Matsuyama,
More informationAssessment and Treatment of Osteoporosis Professor T.Masud
Assessment and Treatment of Osteoporosis Professor T.Masud Nottingham University Hospitals NHS Trust University of Nottingham University of Derby University of Southern Denmark What is Osteoporosis? Osteoporosis
More informationoriginal Se Hwa Kim 1), Tae Ho Kim 1) and Soo-Kyung Kim 2)
Endocrine Journal 2014, 61 (12), 1197-1204 original Effect of high parathyroid hormone level on bone mineral density in a vitamin D-sufficient population: Korea National Health and Nutrition Examination
More informationModule 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC
Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with
More informationVitamin D. Vitamin functioning as hormone. Todd A Fearer, MD FACP
Vitamin D Vitamin functioning as hormone Todd A Fearer, MD FACP Vitamin overview Vitamins are organic compounds that are essential in small amounts for normal metabolism They are different from minerals
More informationTHE IMPORTANCE OF ADEQUATE
ORIGINAL CONTRIBUTION Relationship Between Serum Parathyroid Hormone Levels, Vitamin D Sufficiency, and Calcium Intake Laufey Steingrimsdottir, PhD Orvar Gunnarsson, MD Olafur S. Indridason, MD, MHS Leifur
More informationDr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk
Dr Tuan V NGUYEN Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney NSW Mapping Translational Research into Individualised Prognosis of Fracture Risk From the age of 60, one
More informationOsteoporosis. Overview
v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)
More informationDietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites 1-3
Dietary calcium and vitamin D intake in elderly women: effect on serum parathyroid hormone and vitamin D metabolites 1-3 H Karimi Kinyamu, J Christopher Gallagher, Karen A Rafferty, and Kurt E Balhorn
More informationESPEN Congress Prague 2007
ESPEN Congress Prague 2007 Key papers in the field of nutrition Dietitian Geila S Rozen Key Papers in the field of Nutrition ESPEN 2007 Prague Geila S Rozen Clinical Nutrition Dep. Rambam health campus
More informationVitamin D and Calcium
Vitamin D and Calcium American Association of Clinical Endocrinologists Marina Del Rey, CA September 15, 2018 Albert Shieh, MD MS Assistant Clinical Professor Department of Medicine Division of Endocrinology
More informationFactors related to bone forming inadequate response to treatment (teriparatide/pth 1-84) in patients with severe osteoporosis. Preliminary results
ORIGINALS / Rev Osteoporos Metab Miner 2015 7;4:85-90 85 Gifre L 1, Monegal A 1, Filella X 2, Muxi A 3, Guañabens N 1, Peris P 1 1 Unidad de Patología Metabólica Ósea - Servicio de Reumatología - Hospital
More informationInterpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm
Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis
More informationBreast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime
Breast Cancer and Bone Loss One in seven women will develop breast cancer during a lifetime Causes of Bone Loss in Breast Cancer Patients Aromatase inhibitors Bil Oophorectomy Hypogonadism Steroids Chemotherapy
More informationEfficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents
Osteoporos Int (2008) 19:663 671 DOI 10.1007/s00198-007-0465-2 ORIGINAL ARTICLE Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing
More informationThe efficacy of calcium supplementation alone in elderly Thai women over a 2-year period: a randomized controlled trial
Osteoporos Int () 4:87 877 DOI.7/s98-87-5 ORIGINAL ARTICLE The efficacy of calcium supplementation alone in elderly Thai women over a -year period: a randomized controlled trial R. Rajatanavin & L. Chailurkit
More informationVitamin D Therapy in Patients with Primary Hyperparathyroidism and Hypovitaminosis D
Page 1 of 17 Accepted Preprint first posted on 21 April 2009 as Manuscript EJE-08-0901 Vitamin D Therapy in Patients with Primary Hyperparathyroidism and Hypovitaminosis D JR Tucci, MD, FACP, FACE, Director,
More informationResponse to Teriparatide in Patients with Baseline 25- Hydroxyvitamin D Insufficiency or Sufficiency
J Clin Endocrin Metab. First published ahead of print October 2, 2007 as doi:10.1210/jc.2007-0239 Response to Teriparatide in Patients with Baseline 25- Hydroxyvitamin D Insufficiency or Sufficiency Bess
More informationDEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN
October 2-4, Liverpool, UK EURO SPINE 2013 DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN D. Colangelo, L. A. Nasto, M. Mormando, E.
More informationNew York State County Comparison of Fall-related Hip Fractures of Older Adults and Number of Dual-X-ray Absorptiometry Machines
New York State County Comparison of Fall-related Hip Fractures of Older Adults and Number of Dual-X-ray Absorptiometry Machines Michael Bauer New York State Department of Health Bureau of Occupational
More informationO. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster
DOI 10.1007/s00296-012-2460-y ORIGINAL ARTICLE Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security
More informationOriginal Communication Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it
(2001) 55, 1091 1097 ß 2001 Nature Publishing Group All rights reserved 0954 3007/01 $15.00 www.nature.com/ejcn Original Communication Wintertime vitamin D insufficiency is common in young Canadian women,
More informationVitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D
European Journal of Endocrinology (2009) 161 189 193 ISSN 0804-4643 CLINICAL STUDY Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D J R Tucci 1,2,3 1 Division of Endocrinology,
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Osteoporosis- Do We Need to Think Beyond Bone Mineral Density? Dr Preeti Soni 1, Dr Shipra
More informationEuropean Journal of Endocrinology (1997) ISSN
European Journal of Endocrinology (1997) 137 167 171 ISSN 0804-4643 Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing
More informationJBMR. Serum 25-hydroxyvitamin D [25(OH)D] concentration may or
ORIGINAL ARTICLE JBMR Impact of Calcium and Vitamin D Insufficiencies on Serum Parathyroid Hormone and Bone Mineral Density: Analysis of the Fourth and Fifth Korea National Health and Nutrition Examination
More informationAnnual Rheumatology & Therapeutics Review for Organizations & Societies
Annual Rheumatology & Therapeutics Review for Organizations & Societies Biochemical Markers of Bone Turnover: Definitions and Recommendations for Monitoring Therapy Learning Objectives for Biochemical
More informationVitamin D, Sunlight Exposure, and Bone Density in Elderly African American Females of Low Socioeconomic Status
Vol. 42, No. 1 47 Clinical Research and Methods Vitamin D, Sunlight Exposure, and Bone Density in Elderly African American Females of Low Socioeconomic Status Sally P. Weaver, PhD, MD; Cindy Passmore,
More informationOsteoporosis in Men. Until recently, the diagnosis of osteoporosis. A New Type of Patient. Al s case. How is the diagnosis made?
A New Type of Patient Rafat Faraawi, MD, FRCP(C), FACP Until recently, the diagnosis of osteoporosis in men was uncommon and, when present, it was typically described as a consequence of secondary causes.
More informationCorrelation between Thyroid Function and Bone Mineral Density in Elderly People
IBBJ Spring 2016, Vol 2, No 2 Original Article Correlation between Thyroid Function and Bone Mineral Density in Elderly People Ali Mirzapour 1, Fatemeh Shahnavazi 2, Ahmad Karkhah 3, Seyed Reza Hosseini
More informationCollagen Crosslinks, Any Method
190.19 - Collagen Crosslinks, Any Method Collagen crosslinks, part of the matrix of bone upon which bone mineral is deposited, are biochemical markers the excretion of which provides a quantitative measurement
More informationDisclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis
Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco Disclosure and Conflicts of Interest
More informationHigh Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium Excretion and Bone Resorption Marker
J Bone Metab 214;21:189-194 http://dx.doi.org/1.115/jbm.214.21.3.189 pissn 2287-6375 eissn 2287-729 Original Article High Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium
More informationNutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio
Osteoporosis 1 Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio 1) Objectives: a) To understand bone growth and development
More informationEffects of vitamin D deficiency and daily calcium intake on bone mineral density and osteoporosis in Korean postmenopausal woman
Original Article Obstet Gynecol Sci 2017;60(1):53-62 https://doi.org/10.5468/ogs.2017.60.1.53 pissn 2287-8572 eissn 2287-8580 Effects of vitamin D deficiency and daily calcium intake on bone mineral density
More informationV t i amin i n D a nd n d Calc l iu i m u : Rol o e l in i n Pr P eve v nt n io i n and n d Tr T eatment n of o Fr F actur u es and n d Fa F ll l s
Vitamin D and Calcium: Role in Prevention and Treatment of Fractures and Falls Osteoporosis 21: New Insights In Research, Diagnosis, and Clinical Care Deborah Sellmeyer, MD Director, Johns Hopkins Metabolic
More informationDXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi
DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi Clinical Utility of Bone Densitometry Diagnosis (DXA)
More informationBone mineral density in hypoparathyroid women on LT 4 suppressive therapy. Effect of calcium and 1,25(OH) 2 vitamin D 3 treatment
J Musculoskel Neuron Interact ; ():7-76 Original Article Hylonome Bone mineral density in hypoparathyroid women on LT suppressive therapy. Effect of calcium and,5(oh) vitamin D treatment F. Hawkins, F.
More informationOsteoporosis International. Original Article
Osteoporos Int (2002) 13:257 264 ß 2002 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Combined Calcium and Vitamin D 3 Supplementation
More informationManagement of postmenopausal osteoporosis
Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,
More informationCALCIUM INTAKE MAY be one of the many factors that
0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(2):707 711 Printed in U.S.A. Copyright 2005 by The Endocrine Society doi: 10.1210/jc.2004-1380 Lack of Effect of Calcium Intake
More informationINTRODUCTION. Original Article
J Bone Metab 2015;22:135-141 http://dx.doi.org/10.11005/jbm.2015.22.3.135 pissn 2287-6375 eissn 2287-7029 Original Article Change of Bone Mineral Density and Biochemical Markers of Bone Turnover in Patients
More informationOriginal Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism
www.ijcem.com/ijcem807001 Original Article Fasting Plasma Glucose Levels Are Related to Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism Itoko Hisa 1, Hiroshi Kaji 1, Yoshifumi
More informationIndex. B BMC. See Bone mineral content BMD. See Bone mineral density Bone anabolic impact, Bone mass acquisition
A Acid base balance dietary protein detrimental effects of, 19 Acid base balance bicarbonate effects, 176 in bone human studies, 174 mechanisms, 173 174 in muscle aging, 174 175 alkali supplementation
More informationTestosteroneandVitaminDDeficiencyasRiskFactorsforHipFractureElderlyMalePatientsTimeforVitaminDandTestosteroneReplacement
: F Diseases Volume 16 Issue 4 Version 1.0 Year 2016 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN: 0975-5888
More informationPharmacy Management Drug Policy
SUBJECT: - Forteo (teriparatide), Prolia (denosumab), Tymlos (abaloparatide) POLICY NUMBER: Pharmacy-35 EFFECTIVE DATE: 9/07 LAST REVIEW DATE: 9/29/2017 If the member s subscriber contract excludes coverage
More informationEfficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:
More informationAssociation between Seasonal Changes in Vitamin D and Bone Mineral Density
대한폐경학회지제 17 권제 2 호 2011 Vol. 17, No. 2, August. 2011 Association between Seasonal Changes in Vitamin D and Bone Mineral Density Department of Family Practice and Community Health, Ajou University School
More informationMen and Osteoporosis So you think that it can t happen to you
Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School
More informationThe New England Journal of Medicine EFFECT OF CALCIUM AND VITAMIN D SUPPLEMENTATION ON BONE DENSITY IN MEN AND WOMEN 65 YEARS OF AGE OR OLDER
EFFECT OF CALCIUM AND VITAMIN D SULEMENTATION ON BONE DENSITY IN MEN AND WOMEN 65 YEARS OF AGE OR OLDER BESS DAWSON-HUGHES, M.D., SUSAN S. HARRIS, D.SC., ELIZABETH A. KRALL, H.D., AND GERARD E. DALLAL,
More informationSerum vitamin D metabolites and intestinal calcium absorption efficiency in women 1 3
See corresponding editorial on page 673. Serum vitamin D metabolites and intestinal calcium absorption efficiency in women 1 3 John F Aloia, Ding-Geng Chen, James K Yeh, and Henian Chen ABSTRACT Background:
More information9/26/2016. The Impact of Dietary Protein on the Musculoskeletal System. Research in dietary protein, musculoskeletal health and calcium economy
The Impact of Dietary Protein on the Musculoskeletal System Outline A. The musculoskeletal system and associated disorders Jessica D Bihuniak, PhD, RD Assistant Professor of Clinical Nutrition Department
More informationVitamin D and Calcium Therapy: how much is enough
Vitamin D and Calcium Therapy: how much is enough Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco DISCLOSURE Nothing to disclose 1 RECOMMENDATIONS
More informationThe Endocrine Society Guidelines
Vitamin D and Calcium Therapy: how much is enough DISCLOSURE Daniel D Bikle, MD, PhD Professor of Medicine VA Medical Center and University of California San Francisco Nothing to disclose RECOMMENDATIONS
More informationBone Mineral Density in Thai Patients with Chronic Hepatitis C, before and after Treatment with Pegylated Interferon/Ribavirin Combination ABSTRACT
Original Article 73 before and after Treatment with Pegylated Interferon/Ribavirin Combination Bunchorntavakul C 1 Chotiyaputta W 1 Sriussadaporn S 2 Tanwandee T 1 ABSTRACT Background: Loss of bone mineral
More informationNIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11.
NIH Public Access Author Manuscript Published in final edited form as: Endocr Pract. 2013 ; 19(5): 780 784. doi:10.4158/ep12416.or. FRAX Prediction Without BMD for Assessment of Osteoporotic Fracture Risk
More informationSubmission to the National Institute for Clinical Excellence on
Submission to the National Institute for Clinical Excellence on Strontium ranelate for the prevention of osteoporotic fractures in postmenopausal women with osteoporosis by The Society for Endocrinology
More informationBone and Mineral. Comprehensive Menu for the Management of Bone and Mineral Related Diseases
Bone and Mineral Comprehensive Menu for the Management of Bone and Mineral Related Diseases Innovation to Assist in Clinical Diagnosis and Treatment DiaSorin offers a specialty line of Bone and Mineral
More informationCollagen Crosslinks, Any Method
190.19 - Collagen Crosslinks, Any Method Collagen crosslinks, part of the matrix of bone upon which bone mineral is deposited, are biochemical markers the excretion of which provides a quantitative measurement
More informationLong-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women 1 4
Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women 1 4 Christopher Jensen, Leah Holloway, Gladys Block, Gene Spiller, Ginny
More informationA Case of Cushing Syndrome Diagnosed by Recurrent Pathologic Fractures in a Young Woman
A Case of Cushing Syndrome Diagnosed by Recurrent Pathologic Fractures in a Young Woman JY Han, et al CASE REPORT http://dx.doi.org/10.11005/jbm.2012.19.2.153 Vol. 19, No. 2, 2012 A Case of Cushing Syndrome
More informationOriginal Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT
Original Article Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT Objective: To compare Fracture Risk Assessment Tool (FRAX) calculations with and without bone
More informationBone Mineral Density and Its Associated Factors in Naresuan University Staff
Naresuan University Journal 2005; 13(3): 13-18 13 Bone Mineral Density and Its Associated Factors in Naresuan University Staff Supawitoo Sookpeng *, Patsuree Cheebsumon, Malinee Dhanarun, Thanyavee Pengpan
More informationDifferentiating Pharmacological Therapies for Osteoporosis
Differentiating Pharmacological Therapies for Osteoporosis Socrates E Papapoulos Department of Endocrinology & Metabolic Diseases Leiden University Medical Center The Netherlands Competing interests: consulting/speaking
More informationTanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density 1 3
Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density 1 3 Vin Tangpricha, Adrian Turner, Catherine Spina, Sheila Decastro, Tai C
More information8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview
Disclosure Glucocorticoid induced osteoporosis: overlooked and undertreated? I have no financial disclosure relevant to this presentation Tasma Harindhanavudhi, MD Division of Diabetes and Endocrinology
More informationInadequate Dietary Calcium and Vitamin D Intake in Patients with Osteoporotic Fracture
J Bone Metab 2016;23:55-61 http://dx.doi.org/10.11005/jbm.2016.23.2.55 pissn 2287-6375 eissn 2287-7029 Original Article Inadequate Dietary Calcium and Vitamin D Intake in Patients with Osteoporotic Fracture
More informationThe Impact of Life Style & Dietary Habits on Vitamin D status Among Young Emiratis. Fatme Al Anouti, Ph.D. Zayed University, Abu Dhabi
The Impact of Life Style & Dietary Habits on Vitamin D status Among Young Emiratis Fatme Al Anouti, Ph.D. Zayed University, Abu Dhabi The Sun-Shine Vitamin Vitamin D is unique because it can be synthesized
More informationCASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS
4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending
More informationThe Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake
Korean J Fam Med. 2013;34:43-48 http://dx.doi.org/10.4082/kjfm.2013.34.1.43 The Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake Original Article Junga Kim, Byungsung
More informationRelationship between Decrease in Serum Sodium Level and Bone Mineral Density in Osteoporotic Fracture Patients
J Bone Metab 2015;22:9-15 http://dx.doi.org/10.11005/jbm.2015.22.1.9 pissn 2287-6375 eissn 2287-7029 Original Article Relationship between Decrease in Serum Sodium Level and Bone Mineral Density in Osteoporotic
More informationPART FOUR. Metabolism and Nutrition
PART FOUR Metabolism and Nutrition Advances in Peritoneal Dialysis, Vol. 21, 2005 Maria Mesquita, 1 Eric Wittersheim, 2 Anne Demulder, 2 Max Dratwa, 1 Pierre Bergmann 3 Bone Cytokines and Renal Osteodystrophy
More informationTo understand bone growth and development across the lifespan. To develop a better understanding of osteoporosis.
Nutrition Aspects of Osteoporosis Care and Treatment t Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, OH. Objectives To understand bone growth and development across the lifespan.
More informationOsteoporosis. Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective. Old Definition of Osteoporosis
Current Trend in Osteoporosis Management for Elderly in HK- Medical Perspective Dr Dicky T.K. Choy Physician Jockey Club Centre for Osteoporosis Care and Control, CUHK Osteoporosis Global public health
More informationnogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK
nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK Produced by J Compston, A Cooper,
More information